Cargando…
Mutant-allele tumor heterogeneity in malignant glioma effectively predicts neoplastic recurrence
Intra-tumor heterogeneity (ITH) is one of the most important causes of therapy resistance, which eventually leads to the poor outcomes observed in patients with glioma. Mutant-allele tumor heterogeneity (MATH) values are based on whole-exon sequencing and precisely reflect genetic ITH. However, the...
Autores principales: | Wu, Pengfei, Yang, Wei, Ma, Jianxing, Zhang, Jingyu, Liao, Maojun, Xu, Lunshan, Xu, Minhui, Yi, Liang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6865645/ https://www.ncbi.nlm.nih.gov/pubmed/31788085 http://dx.doi.org/10.3892/ol.2019.10978 |
Ejemplares similares
-
Neurotensin promotes the progression of malignant glioma through NTSR1 and impacts the prognosis of glioma patients
por: Ouyang, Qing, et al.
Publicado: (2015) -
Correction: Neurotensin promotes the progression of malignant glioma through NTSR1 and impacts the prognosis of glioma patients
por: Ouyang, Qing, et al.
Publicado: (2022) -
Tumor heterogeneity and tumor-microglia interactions in primary and recurrent IDH1-mutant gliomas
por: Blanco-Carmona, Enrique, et al.
Publicado: (2023) -
Downregulation of miR-16 via URGCP pathway contributes to glioma growth
por: Hong, Liang, et al.
Publicado: (2017) -
Prediction of Cancer-Specific Survival of Brainstem Glioma in Children Based on Risk Stratification Model
por: Sun, Kai, et al.
Publicado: (2022)